Sanofi, Regeneron Can't Patent Asthma Prevention Tool
European officials have revoked a Sanofi and Regeneron patent for an asthma treatment after the two biomedical companies said they no longer approved of the text. ...To view the full article, register now.
Already a subscriber? Click here to view full article